Biotech Firm Sirna Heads to California

Boulder's Sirna Therapeutics plans to relocate its headquarters to San Francisco, citing attractive financial incentives and the need to be near investment bankers and qualified workers. Sirna is one of only a handful of publicly traded biotech companies based in Colorado, and its move highlights some of the challenges the state faces in growing the industry here.

Bizjournals (http://www.bizjournals.com/industries/health_care/biotechnology/2005/03/07/denver_story2.html)